CMA
BTCY

Cedar Mountain Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Cedar Mountain Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,501
Closed -$2.25K – 364
2024
Q2 		$2.25K Hold
2,501
– – ﹤0.01% 268
2024
Q1 		$3.7K Hold
2,501
– – ﹤0.01% 246
2023
Q4 		$2.88K Hold
2,501
– – ﹤0.01% 245
2023
Q3 		$5.35K Buy
+2,501
New +$6.04K ﹤0.01% 208
2023
Q2 		– Sell
-2,500
Closed -$6.97K – 313
2023
Q1 		$6.97K Hold
2,500
– – ﹤0.01% 188
2022
Q4 		$6.72K Hold
2,500
– – ﹤0.01% 185
2022
Q3 		$12K Hold
2,500
– – ﹤0.01% 149
2022
Q2 		$27K Buy
+2,500
New +$21.8K 0.01% 99
2022
Q1 		– Sell
-2,500
Closed -$60K – 351
2021
Q4 		$60K Buy
2,500
+1,667
+200% +$39.3K 0.02% 71
2021
Q3 		$15K Buy
+833
New +$15.6K 0.01% 140

Other funds holding BTCY

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $450M AUM 41.19% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
PWA
Provenance Wealth Advisors Fort Lauderdale, Florida $1.05B AUM 18.67% 1-Year Est. Return
PGAM
Princeton Global Asset Management Princeton, New Jersey $698M AUM 31.09% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Cedar Mountain Advisors's BTCY Position: Q3 2024 in Review

Cedar Mountain Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 2,501 shares — an estimated $2.25K sold.

Cedar Mountain Advisors first reported a position in BTCY in Q3 2021 and held it in 10 quarters. The position peaked at $60K in Q4 2021. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • Cedar Mountain Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Cedar Mountain Advisors sold 2,501 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $2.25K.
  • Cedar Mountain Advisors first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Cedar Mountain Advisors's Biotricity, Inc. Common Stock position peaked at $60K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on Cedar Mountain Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.